Thought Leadership

Hear From Our Team of Experts

Amplity Health is a leader in the healthcare industry

From healthcare training to commercial solutions, Amplity’s position in the life science ecosystem affords us first-hand access to trends and market developments to provide value-added answers to your commercialization strategy challenges. Our clients rely on our timely, relevant, and insightful thought leadership when making medical or commercial decisions. As a contract commercial organization with decades of experience, you can count on us for valuable global healthcare solutions.

Webinar: Simplifying the Complexities of the Reimbursement Landscape

Simplifying the Complexities of the Reimbursement Landscape The current PBM & GPO landscapes have evolved rapidly over the last five years. Pharma’s Brand, Marketing, and Sales teams must maintain a thorough understanding of what’s changed, why, and how it effects their p...

Which Post-Pandemic Model Is Best for Remote Engagement Teams

Work from Call Center or Work from Home? Understanding the Benefits of Each to Optimize Your Remote Teams As the industry continues to revive shuttered offices in response to COVID’s retreat, business leaders are deciding whether to reopen their inbound and outbound facili...

Clinical Trial Liaisons: The “Missing Link” Between Pharma and Clinical Trial Efficiency

Bread and butter. Hydrogen and oxygen. Manufacturer and CRO. Among pairings that have stood the test of time is that of a pharmaceutical manufacturer and its Contract Research Organization (CRO). CROs are trusted to provide mission-critical services for their pharma clients’ d...

Webinar: Federal Market Access Navigating New VA Market Dynamics

How to reframe the VA “Value” Proposition to ensure success in 2022 In this webinar recording, Amplity’s VA practice lead and former VA VISN Pharmacy Executive, Jannet Carmichael, PharmD, reviews strategies to achieve meaningful awareness and adoption in today’s complex VA la...

The Resounding Call for Blended Customer Engagement Models

Recent research reveals 30% of HCP engagements are done digitally. Pharmaceutical and device companies must adopt a blended customer engagement model to allow for multiple channels to be available at any time based on the needs of their customer and the needs of their brand. ...

Oncology Expertise - Clinical Trials to Commercialization

      Amplity's Robust Experience in Oncology Healthcare At Amplity, we understand that every Oncology asset is uniquely complex. We're here to help global pharma companies navigate unchartered territory. We're a team of over ~1,500 professionals w...

Amplity Insights Database to Determine the True Prevalence of Disease

 Exploring Real-World Evidence Data Sources This is the second article in a series exploring Amplity Insights, the industry’s only database containing unstructured full-text transcripts of dictated physician notes from physician–patient encounters. While structured dat...

Enabling Medical to Take a Leadership Position on Strategy

As a leader in Medical Affairs, how do you enable your team to take a leadership position on strategy within the organization? Amplity Health's Executive Chairman Suzanna Lawrence sat down for a conversation with Danie du Plessis, Executive VP of Medical Affairs at Kyowa Kirin...

Answering the 3 Key Questions Pharma Must Consider When Deploying FRMs at the Launch of a New Specialty Brand

Field Reimbursement Managers (FRMs) are highly skilled professionals operating in a specialized non-sales role supporting healthcare professionals and office staff in defined territories. FRMs use their extensive knowledge of insurance coverage, patient assistance programs, an...

Do Virtual Teams Need to Work Together in a Call Center?

Bringing Teams Back to Call Centers vs. Continuing Remote Work Arrangements As COVID-19 case counts drop nationwide, pharmaceutical, medical device, and biotech companies—like many other industries—are considering whether to reopen the call centers that once housed inbound an...

Webinar: Exploring Current Payer Price Sensitivities

Understanding the relationship between pharmaceutical manufacturers and payers in 2022 In this webinar recording, Amplity's Cheryl Nagowski and Dan Cusack walk participants through the current thinking around payer price sensitivities. This session explores why manufacturers ...

Assessing Prevalence of Hypoglycemia in a Medical Transcription Database

The following publication developed by Novo Nordisk and leveraging Amplity Insights' unique medical transcription database supports the hypothesis that hypoglycemia is underreported in traditional claims or electronic medical record (EMR) databases. Using an unstructure...

Closing the Insight Gaps Left by Structured EMR Datasets

Realizing the Benefits of Unstructured Data from Medical Transcription Records While structured datasets from EMR systems serve an important business need and provide analytical value, they leave large gaps related to patient characteristics and treatment decisions. Fortuna...

Amplity Insights Poster Gallery

Amplity Insights_Scientific Poster Feasibility of Use of Medical Transcription Data For Real World Evidence Generation in the United States: A Pilot Study of Patients With Systemic Lupus Erythematosus (SLE) Initiated on Belimumab   Amplity Insights_Scientific Poster_...

When Should You Reach Out to Your Navigator?

This article - written by Amplity's Sharon Gentry - was originally published in CONQEUR magazine Navigators help patients and caregivers overcome healthcare barriers and provide them with timely access to quality medical and psychosocial care before a cancer diagnosis and thr...

The Value of Virtual Interactions with Key Opinion Leaders

Overview For decades, pharmaceutical companies have consulted with key healthcare providers (HCPs) and other key opinion leaders who have their finger on the pulse of the treatment landscape. In face-to-face interactions, HCPs have provided insight into a wide range of subjec...

The Reciprocal Value of Patient and Caregiver Support Programs

Overview The recent proliferation of patient and caregiver support programs is being driven by greater patient involvement in health decisions, increasing attention on patient outcomes, and the growth of specialty drugs that require additional patient support. These programs ...

Webinar: Patient Access to Specialty Pharmaceuticals

We are hosting a three-part webinar series on the trends and challenges surrounding patient access to recently approved specialty products in 2022 and beyond. This series is hosted by Frank Arena, Senior Vice President at Amplity Health with over 20 years of experience at Nova...

Why the Nurse Navigator Is Essential to the Patient

This article - written by Amplity Health's Sharon Gentry - was published in PM360 online magazine  Patient navigation is a health delivery support strategy that addresses barriers to care and assists in explaining the maze of information by enhancing patient shared dec...

Reaching Key Healthcare Providers and Patients: The Importance of Strategic Biopharmaceutical Publications

Overview Each year, between 700,000 and 900,000 medical journal articles are added to the PubMed database managed by The U.S. National Library of Medicine.1 Many of these articles focus on key findings from biopharmaceutical research, conducted by companies that invest more t...

The Journey of Oncology Navigation

This article - written by Amplity Health's Sharon Gentry - was originally published in American Nurse online magazine Key takeaways: Patient navigation aims to increase health equity among patients with cancer and can be applied in a variety of inpatient and outpatient s...

Understanding Rare Diseases and Orphan Drug Marketing

While Covid-19 has impacted populations across the globe, it may have had an even greater effect on patients suffering from rare diseases. The pandemic has disrupted orphan drug research, causing trial delays, site closures, and even program cancellations. On a positive note, ...

Inbound Patient Support Post-Pandemic Trends & Challenges

At the onset of the COVID-19 pandemic, the number of inbound calls from both patients and HCPs climbed to unprecedented levels. The need for high-quality on-demand customer care became more evident than perhaps ever before. Inbound patient support teams suddenly found themselv...

Presenting & Facilitating with Impact

The ability to speak in public is a key skill for nearly everyone in a customer-facing role. But for those in certain healthcare positions, the need for expert communication skills goes even deeper. For example, field-based medical professionals are frequently required to pres...

Partnering Patient Advocacy Organizations for Today and Tomorrow

Partnered Podcast hosted by MAPS Field Medical: Partnering Patient Advocacy Organizations for Today and Tomorrow Amplity's Karen Shopmyer is featured in the latest podcast produced by the Medical Affairs Professional Society (MAPS). Listen in on Karen's interview with Dr....

Expanding Customer-Facing Medical Teams Beyond MSLs

Thank you for your download! Click below to begin download. DOWNLOAD You just took the first step in evolving your customer-facing Medical strategy to meet the growing needs of your customers. Let Amplity be your true partner in maximizing the utility and value of your Med...

Untapped Opportunities for Oncology Medical Affairs

Striving for better access and more equitable cancer care in communities nationwide Introduction Pharmaceutical companies’ traditional medical education model relies on prominent researchers and publishers in the oncology space, otherwise known as Key Opinion Leaders (KOLs),...

Mentoring Your Own Career, Part of Amplity’s Women in Leadership Blog Series

Regardless of the industry you work in, the size of the company you work for, or what kind of job you have, it’s generally well accepted that having a mentor will help guide you through your career. Finding a mentor that will help you maintain resilience, make big decisions an...

How to Schedule and Conduct Compliant Scientific Discussions in Today's Remote Landscape

Cultivating and preserving relationships with Health Care Professionals (HCPs) in a post-COVID environment Pharma continues to evolve in the way Medical Affairs engages with external stakeholders, primarily HCPs and Key Opinion Leaders (KOLs). Pre-pandemic, it wasn’t unusual ...

Reframing Key Account Management in the Specialty Drug Era

When the Greek philosopher Heraclitus wrote “There is nothing permanent except change,” he probably wasn’t thinking about the modern pharmaceutical industry. Nevertheless, his notion of the constancy of change fits our business perfectly. Indeed, today’s healthcare delivery mo...

Lessons From My First Job, Part of Amplity’s Women in Leadership Blog Series

I remember my first job right out of college. I was 21 years old and had accepted a position in corporate insurance sales, a role that was dominated by men. I walked into the office in my skirt suit and pantyhose and pretended that I was ready to take on the world! Secretly, I...

A Guide to Remote Communication

May 2021: COVID-19 has disrupted field team activity, but it doesn’t have to bring it to a standstill. Arm your field teams with the skills needed to effectively engage HCPs remotely. As an industry, we are yet to appreciate what the “new normal” will look like. But one thing...

Why You Need Live Virtual Learning In Your Training Curriculum

COVID-19 forced organizations worldwide to slam the brakes on normal processes. The coronavirus pandemic spawned massive shifts as businesses scaled back, delayed, or even cancelled vital education and training programs. Looking forward to the immediate post-COVID phase, ex...

The Total Office Call: Uncovering Valuable Information and Building Rapport

Pre-COVID-19, Pharmaceutical Sales Representatives (reps) would walk into a medical office/facility healthcare professional's (HCP) office, politely introduce themselves and ask to see the prescriber. While they were waiting, they might've made casual conversation with the rec...

Remote Engagement During Pre-Launch: Maximizing Sales and Market Share Through Early Planning

Every pharma sales leader knows that pre-launch HCP targeting is crucial to a successful brand introduction. In our experience, identifying and adequately profiling targets may be the most critical task in the pre-launch phase. Why? Because in addition to driving launch potent...

The Best Advice I’ve Ever Received Part of Amplity’s Women in Leadership Blog Series

Advice can come in many different shapes and forms: a family member, a mentor or colleague, a fortune cookie. For me, the best advice I ever received came from an internet meme: “Be the woman who straightens another woman’s crown and never tells the world it was crooked.” That...

The Adverse Events Specialist Role: Providing On-Demand Adverse Event Support to Clinical Staff

Specialty drugs, used to treat complex conditions, may cost from $10,000 to $100,000 or even more per therapy course. Growth in the use of specialty drugs continues to outpace the overall drug market. As reported by the Drug Channels Institute 2020 Report, specialty drugs now ...

Field Reimbursement Managers: Overcoming Patient Access Barriers Through One-on-One Support

Field Reimbursement Managers (FRMs) are highly skilled professionals operating in a specialized non-sales role supporting healthcare professionals and office staff in defined territories. FRMs use their extensive knowledge of insurance coverage, patient assistance programs, an...

What is World-Class Learning Facilitation?

Here at Amplity, our learning facilitators are often asked how they got to be so good at what they do. Think about it: we have all experienced that moment when a teacher, speaker, or group leader inspired us to strive for excellence. This can involve creating an environment in...

Primary Drivers of Effective Digital Learning

As 2020 unfolded, the COVID-19 shutdown pushed in-person business meetings off the calendar and replaced them with virtual meetings. Since then, the global experiment with forced digital communication — from 1:1 meetings and team get-togethers to fully remote conferences and v...

Women in Leadership, a new Blog Series

From a very young age, my mom always reminded me that I could be anything I wanted to be when I grew up. This sentiment always came in the form of a story about how she was only ever encouraged to be a secretary, teacher, or nurse. She had chosen to be a nurse, and w...

Answering the ‘why, when, what and who’ when launching a Companion Diagnostic

h5, h3 { color:#8246af; } The emerging segment of immunotherapy I recently saw a statistic that stated it can take up to 4.5 years for a biomarker to reach an 80% testing rate among patients. Looking back over my experience working in Precision Medicine in the last d...

Medical Affairs in a Post-COVID Environment: A New Customer Engagement Model

COVID-19 has had devastating effects on individuals, economies, and health systems around the world. If there is a pandemic silver lining, part of it may be that the disruption has created an opportunity for biopharmaceutical companies of all sizes to revisit how they engage w...

Laboratory Science Liaisons Support Novel Biomarker Testing for New Companion Diagnostic Case Study

January 2021: How Amplity helped a global Oncology pharma company establish their brand as a leader in Precision Medicine. Hit the "download" button below to see the full presentation. DOWNLOAD

COVID-19 Trends in the Amplity Real-World Research Database

Coronaviruses are human and animal pathogens. In late 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified from a cluster of cases occurring in the city of Wuhan, China, and subsequently spread throughout the world giving rise...

The Salesforce of the Future

COVID-19 has driven vast changes in what healthcare providers need and value from pharma companies, and as a result, the industry is striving to develop new ways to engage with physicians. Experts say this is just the beginning of a long journey and as the health ecosystem con...

Creating Value with Real World Data and Natural Language Processing

The era of big data in health care is upon us, powered by the digitization of all healthcare information. Fundamental to this trend has been the widespread adoption of the electronic health record (EHR). (1) However, enthusiasm regarding the use of EHR data in research has bee...

Focus on Rare Diseases and Orphan Drug Marketing

Taken together, rare diseases afflict as many as 30 million Americans - nearly 10% of the US population. To date, as many as 8,000 rare diseases have been identified but only 5% of rare diseases currently have any FDA-approved drug treatment. Up to 80% of these disorders hav...

Can Artificial Intelligence Safely Enable Field Personnel’s Use of Free Text

Today’s pharma-industry call notes systems almost universally use only static dropdown checklist options while prohibiting free-text entries. And although many leaders think these dropdown-only systems enhance compliance, they actually hamper it by failing to meet today’s stan...

Time to Embrace Companion Diagnostics to Accelerate Precision Medicine

Conventional pharmacotherapy is characterized by a trial-and-error approach in which medications are tried sequentially.1 The success rates from treatment with this approach are relatively low, and efficacy and safety outcomes can vary substantially between patients.1 The caus...

Remote Engagement and Outsourcing Survey Results

Check out what Pharma and Biotech decision makers (N=30) who influence the Remote Engagement strategy had to say in their surveys. Hit the "download" button below to see all the results.    DOWNLOAD

Engaging Key Stakeholders to Deliver Positive Outcomes

Rare diseases — those afflicting fewer than 200,000 individuals in the United States — individually affect relatively small groups of patients. But taken together, rare diseases afflict as many as 30 million Americans, nearly 10% of the US population. To date, as many as 8,000...

A Detailed Examination of Practice Pressures and Desired Interaction with Pharma Manufacturers

Oncology is — and will continue to be for the foreseeable future — pharma’s powerhouse. In its latest edition of World Preview 2016, Outlook to 2022, Evaluate Pharma ® predicts that oncology will remain the largest segment in 2022 with an expected annual growth of 12.5% per ye...

CONQUER: A Magazine by and for the Cancer Community

In the past decade, the field of oncology has undergone a marked shift in patient education and marketing.With more therapies available than ever before and greater patient involvement in treatment decisions, oncology nurse navigators face the perennial challenge of providing ...

Amplity’s Blended Engagement Model A New Post-COVID Health Care Provider (HCP) Customer Engagement Model for Pharma

COVID-19 has had a profound impact on the commercialization of pharmaceuticals in the United States. Health Care Provider (HCP) information-seeking needs and preferences have changed dramatically in response to the outbreak, as have the options for pharmaceutical manufacturers...

TL

Ready to discuss how we can partner to create better healthcare solutions?

© Amplity Health.
All Rights Reserved.

Ready to discuss how we can partner?